Although the rates for squamous cell carcinoma (SCC) spreading to other parts of the body are low, the overall incidence of the disease is high, making the number of SCC fatalities greater than that of melanoma. “While our current staging systems have improved risk prediction, we still need to get better at predicting which squamous cell carcinomas will metastasize,” says …

In this press release, Dr. Ibrahim comments on the utility of the new gene expression profiling test from Castle Biosciences for squamous cell carcinoma (SCC).  We are seeing so many cases each day of SCC at Rochester Dermatologic Surgery. Although most of these cancers are cured easily in our office with surgery, we know that as many as 1 in …

Dr. Ibrahim has been invited as a faculty member to speak at the Vegas Cosmetic Surgery and Aesthetic Dermatology Conference in Las Vegas in June. This is among the world’s greatest gatherings of specialists dedicated to aesthetic medicine. This year’s conference will be available in both in-person and live stream options. Dr. Ibrahim will be speaking about the powerful combination of Sciton MOXI …

In this article, Dr. Ibrahim is interviewed by Dermatology Times to discuss some of the recent advances in the field of skin cancer. As a key opinion leader in the field, Dr. Ibrahim and the team at Rochester Dermatologic Surgery, are deeply involved in the development of the latest techniques in skin cancer treatment and management. This is what he …

In this article, Dr. Ibrahim is interviewed by New You Magazine about the transformative results seen with Halo resurfacing of the skin. As a member of the Sciton lasers strategic advisory board, Dr. Ibrahim has a wealth of knowledge and experience in obtaining incredible results with the interaction of lasers and the skin. Conditions such as uneven color and texture, …